Research & Literature

Angiogenic and Inflammatory Vitreous Biomarkers Associated With Increasing Levels of Retinal Ischemia.

Kovacs K, Marra KV, Yu G, et al.

Investigative ophthalmology & visual science 2015; (56(11)):6523-30 doi:10.1167/iovs.15-16793.

Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.

Sun Y, Liang Y, Zhou P, et al.

BMC ophthalmology 2016; (16(1)):150 doi:10.1186/s12886-016-0327-9.

Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma.

Kim YH, Sung MS, Park SW

Korean journal of ophthalmology : KJO 2017; (31(4)):343-350 doi:10.3341/kjo.2016.0067.

Neovascular Glaucoma: A Retrospective Review from a Tertiary Eye Care Center in Mexico.

Lazcano-Gomez G, R Soohoo J, Lynch A, et al.

Journal of current glaucoma practice 2017; (11(2)):48-51 doi:10.5005/jp-journals-10028-1222.

Optical Coherence Tomography Angiography Before and After Bevacizumab Injection in Ocular Ischemic Syndrome.

Choi EY, Lee SC, Kim M

Retina (Philadelphia, Pa.) 2018; (38(3)):e23-e25 doi:10.1097/IAE.0000000000001981.

Anterior Segment Imaging for Angle Closure.

Chansangpetch S, Rojanapongpun P, Lin SC

American journal of ophthalmology 2018; (188()):xvi-xxix doi:10.1016/j.ajo.2018.01.006.

Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.

Vale S, Montalvo L, Baez E, Oliver AL

American journal of ophthalmology case reports 2018; (9()):45-47 doi:10.1016/j.ajoc.2018.01.007.

Iris Thickness and Severity of Neovascular Glaucoma Determined Using Swept-Source Anterior-segment Optical Coherence Tomography.

Nakakura S, Kobayashi Y, Matsuya K, et al.

Journal of glaucoma 2018; (27(5)):415-420 doi:10.1097/IJG.0000000000000921.

Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors.

Gaynon MW, Wong RJ, Stevenson DK, Sunshine P

Journal of perinatology : official journal of the California Perinatal Association 2018; (38(10)):1295-1300 doi:10.1038/s41372-018-0177-9.

Risk Factors and Preventive Effects of Laser Panretinal Photocoagulation for Neovascular Glaucoma after Ophthalmic Stereotactic Radiotherapy.

Ueda E, Yoshikawa H, Arakawa S, et al.

Nippon Ganka Gakkai zasshi 2016; (120(10)):689-95.

Evaluation of the angle of the anterior chamber using ultrasound biomicroscopy, gonioscopy and a Van Herick examination.

Carrizosa Murcia M, Rey Rodríguez DV

Archivos de la Sociedad Espanola de Oftalmologia 2019; (94(3)):114-118 doi:10.1016/j.oftal.2018.09.011.

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Sakamoto M, Hashimoto R, Yoshida I, et al.

Clinical ophthalmology (Auckland, N.Z.) 2018; (12()):2323-2329 doi:10.2147/OPTH.S184959.

Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes.

Suda M, Nakanishi H, Akagi T, et al.

Clinical ophthalmology (Auckland, N.Z.) 2018; (12()):2439-2449 doi:10.2147/OPTH.S183689.

Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor.

Li Y, Hu D, Lv P, et al.

European journal of ophthalmology 2020; (30(3)):500-505 doi:10.1177/1120672119832785.

Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Rong AJ, Swaminathan SS, Vanner EA, Parrish RK

American journal of ophthalmology 2019; (204()):62-69 doi:10.1016/j.ajo.2019.02.038.

Acute angle closure glaucoma from spontaneous massive subretinal hemorrhage.

Sosuan GMN, Domingo RED

GMS ophthalmology cases 2019; (9()):Doc15 doi:10.3205/oc000104.

Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Rong AJ, Swaminathan SS, Vanner EA, Parrish RK

American journal of ophthalmology 2019; (205()):201-202 doi:10.1016/j.ajo.2019.04.029.

Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study.

Liang X, Zhang Y, Li YP, et al.

Diabetes therapy : research, treatment and education of diabetes and related disorders 2019; (10(5)):1801-1809 doi:10.1007/s13300-019-0644-0.

Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma.

Elwehidy AS, Bayoumi NHL, Badawi AE, et al.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; (8(4)):308-313 doi:10.1097/APO.0000000000000248.

Carotid Endarterectomy for Ocular Ischemic Syndrome: A Case Report and Review of the Literature.

Lauria AL, Koelling EE, Houghtaling PM, White PW

Annals of vascular surgery 2020; (67()):567.e9-567.e12 doi:10.1016/j.avsg.2020.03.005.

Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.

Sun C, Zhang H, Tang Y, et al.

Current eye research 2020; (45(12)):1504-1513 doi:10.1080/02713683.2020.1762226.

Angle-closure assessment in anterior segment OCT images via deep learning.

Hao H, Zhao Y, Yan Q, et al.

Medical image analysis 2021; (69()):101956 doi:10.1016/j.media.2021.101956.

Neovascular glaucoma - A review.

Senthil S, Dada T, Das T, et al.

Indian journal of ophthalmology 2021; (69(3)):525-534 doi:10.4103/ijo.IJO_1591_20.

Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential.

Rani PK, Sen P, Sahoo NK, et al.

International ophthalmology 2021; (41(7)):2359-2368 doi:10.1007/s10792-021-01789-y.

Early Surgical Intervention for Neovascular Glaucoma in a Patient with Diabetes.

Husain KA, Alaali H, Alderazi H

Cureus 2021; (13(6)):e15420 doi:10.7759/cureus.15420.

Types of Glaucoma and Associated Comorbidities Among Patients at King Abdulaziz Medical City, Jeddah.

Talaat K, Fathi OT, Alamoudi SM, et al.

Cureus 2021; (13(6)):e15574 doi:10.7759/cureus.15574.

Intermediate-term outcomes of the Aurolab aqueous drainage implant in neovascular glaucoma.

Gnanavelu S, Puthuran GV, Chiranjeevi KP, et al.

The British journal of ophthalmology 2023; (107(3)):355-360 doi:10.1136/bjophthalmol-2021-319999.

Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure.

Senthil S, Chary R, Ali MH, et al.

Indian journal of ophthalmology 2021; (69(11)):3341-3348 doi:10.4103/ijo.IJO_1516_21.

Incidence of and Risk Factors for Postoperative Hyphema After 23-Gauge Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.

Nie YH, Zhang Y, Li F, et al.

International journal of general medicine 2021; (14()):7277-7284 doi:10.2147/IJGM.S332485.

Primary slow-coagulation transscleral cyclophotocoagulation laser treatment for medically recalcitrant neovascular glaucoma.

Khodeiry MM, Lauter AJ, Sayed MS, et al.

The British journal of ophthalmology 2023; (107(5)):671-676 doi:10.1136/bjophthalmol-2021-319757.

The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma.

Bai L, Wang Y, Liu X, et al.

Frontiers in medicine 2021; (8()):766032 doi:10.3389/fmed.2021.766032.

Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma.

DeBoer C, Wong B, Ameri H

Frontiers in bioscience (Landmark edition) 2022; (27(1)):24 doi:10.31083/j.fbl2701024.

Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion.

Lee YH, Kim YC

Scientific reports 2022; (12(1)):2051 doi:10.1038/s41598-022-06121-x.

[A case of atypical iris corneal endothelial syndrome].

Cheng YY, Cheng SM, Xu HJ, et al.

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2022; (58(2)):146-148 doi:10.3760/cma.j.cn112142-20211216-00588.

Etiology, pathogenesis, and diagnosis of neovascular glaucoma.

Călugăru D, Călugăru M

International journal of ophthalmology 2022; (15(6)):1005-1010 doi:10.18240/ijo.2022.06.20.

Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report.

Asif H, Si Z, Quan S, et al.

Case reports in ophthalmological medicine 2022; (2022()):4959522 doi:10.1155/2022/4959522.

Survival in Patients with Neovascular Glaucoma Following Tube Shunt Implant or Cyclodestructive Procedure.

Zhou Y, Coleman S, Boysen J, et al.

Journal of current glaucoma practice 2022; (16(2)):74-78 doi:10.5005/jp-journals-10078-1357.

The role of Anti-VEGF agents in treatment of neovascular glaucoma.

Palfi Salavat MC, Șeclăman EP, Barac R, et al.

Romanian journal of ophthalmology 2022; (66(3)):209-213 doi:10.22336/rjo.2022.41.

Neovascular Glaucoma: An Update.

Kalogeropoulos D, Moussa G, Sung VC, et al.

Klinische Monatsblatter fur Augenheilkunde 2023; (240(3)):305-315 doi:10.1055/a-1956-9348.

Short-Term Outcomes of Trabeculectomy With or Without Anti-VEGF in Patients With Neovascular Glaucoma: A Systematic Review and Meta-Analysis.

Zhou X, Chen J, Luo W, Du Y

Translational vision science & technology 2023; (12(9)):12 doi:10.1167/tvst.12.9.12.

Management of Neovascular Glaucoma.

Lidder AK, Paranjpe V, Lauter AJ

International ophthalmology clinics 2023; (63(4)):167-183 doi:10.1097/IIO.0000000000000480.

Micropulse diode laser therapy in refractory glaucoma.

Issiaka M, Zrikem K, Mchachi A, et al.

Advances in ophthalmology practice and research 2023; (3(1)):23-28 doi:10.1016/j.aopr.2022.10.003.

Widefield swept-source optical coherence tomography angiography metrics associated with neovascular glaucoma in patients with proliferative diabetic retinopathy.

Lu ES, Cui Y, Le R, et al.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2024; (262(4)):1111-1120 doi:10.1007/s00417-023-06290-z.

Trabeculectomy with concurrent intravitreal bevacizumab in neovascular glaucoma.

Khan SM, Rao A

Indian journal of ophthalmology 2024; (72(3)):386-390 doi:10.4103/IJO.IJO_676_23.

Surgical outcomes including visual improvement after glaucoma surgery in patients with neovascular glaucoma.

Chey JH, Lee CK

Heliyon 2024; (10(7)):e28938 doi:10.1016/j.heliyon.2024.e28938.

The efficacy of adjunctive mitomycin C and/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic review.

Figueiredo R, Barbosa-Breda J

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2024; (262(10)):3273-3286 doi:10.1007/s00417-024-06476-z.

[Current views on pathogenesis and treatment of neovascular glaucoma].

Fedoruk NA

Vestnik oftalmologii 2024; (140(3)):110-116 doi:10.17116/oftalma2024140031110.

The effect of the intercellular adhesion molecule-1 and glycated haemoglobin on the management of diabetic neovascular glaucoma.

Guzun OV, Zadorozhnyy OS, Velychko LM, et al.

Romanian journal of ophthalmology 2024; (68(2)):135-142 doi:10.22336/rjo.2024.25.

Efficacy and Safety of Laser Therapy on Ischemic Central Retinal Vein Occlusion: A Systematic Review and Analysis of Clinical Studies.

Alotaibi GF, Seraj H, AlMulihi QA, et al.

Cureus 2024; (16(6)):e62292 doi:10.7759/cureus.62292.

Long-term outcome of surgical management in neovascular glaucoma: A retrospective, multicentric study.

Pegu J, Garg P, Shakya R, et al.

Indian journal of ophthalmology 2025; (73(Suppl 2)):S254-S259 doi:10.4103/IJO.IJO_3145_23.

Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions.

Palmer LD, Peterson JD, Evans JK, et al.

Ophthalmology and therapy 2024; (13(11)):3013-3024 doi:10.1007/s40123-024-01039-1.

A neural network model for predicting the effectiveness of treatment in patients with neovascular glaucoma associated with diabetes mellitus.

Guzun OV, Zadorozhnyy OS, Vychuzhanin VV, et al.

Romanian journal of ophthalmology 2024; (68(3)):294-300 doi:10.22336/rjo.2024.53.

Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease-Interplay Between Inflammation and Oxidative Stress.

Srejovic JV, Muric MD, Jakovljevic VL, et al.

International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111850.

Early postoperative bevacizumab for preventing neovascular glaucoma in phacovitrectomy for proliferative diabetic retinopathy.

Hwang S, Hong EH, Kang MH, Shin YU

Scientific reports 2025; (15(1)):1231 doi:10.1038/s41598-025-85667-y.

Predictors of anterior chamber angle status at the time of neovascular glaucoma diagnosis.

Wang J, Kanter J, Qiu M

American journal of ophthalmology case reports 2024; (36()):102096 doi:10.1016/j.ajoc.2024.102096.

Carotid revascularization and circle of Willis in ocular ischemic syndrome: association with neovascular glaucoma and visual prognosis.

Cheng XR, Meng ZY, Zhao L, et al.

Journal of neurointerventional surgery 2025; doi:10.1136/jnis-2024-022959.

Association between stress hyperglycemia ratio and neovascular glaucoma in patients with proliferative diabetic retinopathy.

Fang C, He D, Shen M, et al.

BMC ophthalmology 2025; (25(1)):163 doi:10.1186/s12886-025-03982-4.

Medical and surgical management of neovascular glaucoma.

Yun JS, Santina A, Tseng VL

Current opinion in ophthalmology 2025; (36(5)):434-441 doi:10.1097/ICU.0000000000001151.

A Comparison of All-Cause Mortality in Patients Who Required Glaucoma Surgery for Neovascular Glaucoma or Primary Open-Angle Glaucoma: A Retrospective Cohort Study.

Palmer LD, Kauffman LD, Russell GB, et al.

Vision (Basel, Switzerland) 2025; (9(2)) doi:10.3390/vision9020049.

Clinical Challenges with Neovascular Glaucoma-Patient Tailored Strategies and Outcomes.

Rao A, Padhi TR, Khan SM

Nigerian medical journal : journal of the Nigeria Medical Association 2025; (66(2)):449-456 doi:10.71480/nmj.v66i2.586.

Comparison of angle-closure detection between automated gonioscopy and anterior-segment optical coherence tomography.

Takagi Y, Asano R, Morioka Y, et al.

PloS one 2025; (20(9)):e0332590 doi:10.1371/journal.pone.0332590.

Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation.

Fiddimore E, Al-Janabi A, Sulur Sundararajan R, Gallagher K

Eye (London, England) 2026; (40(1)):77-82 doi:10.1038/s41433-025-04099-0.

Mortality in neovascular glaucoma.

Taylor KC, Shiromani S, Smolar ALO, et al.

Indian journal of ophthalmology 2026; (74(1)):81-86 doi:10.4103/IJO.IJO_1421_25.

Neovascularization of the Iris/Angle in Primary Angle Closure Glaucoma: A Distinct Entity!

Angmo D, Warjri GB, Verma S, et al.

Journal of current glaucoma practice 2025; (19(4)):229-233 doi:10.5005/jp-journals-10078-1499.

Preoperative intravitreal injection of conbercept improves the efficacy of neovascular glaucoma surgery.

Chen L, Zhou J, Lou Q, et al.

American journal of translational research 2025; (17(12)):9927-9935 doi:10.62347/BJQD4198.

Long-Term Risk of Mortality and Systemic Morbidity in Neovascular Glaucoma: A Multicenter Retrospective Cohort Study.

Margolis R, Vasu P, Dorairaj SK

Ophthalmology. Glaucoma 2026; doi:10.1016/j.ogla.2026.01.017.